Recordati Industria Chimica e Farmaceutica S.p.A

Research Recordati Industria Chimica e Farmaceutica S.p.A (RER1) on Bullrun: valuation model: 15.4% undervalued, market cap EUR 10.41B, P/E 22.7, dividend yield 2.8%. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRER1
• ExchangeF
• CountryItaly
• SectorHealthcare
• IndustryDrug Manufacturers - General
• CurrencyEUR
• Valuation signal15.4% undervalued
• Market capEUR 10.41B
• P/E22.7
• Dividend yield2.8%
• Financial periodFY2025

Valuation Snapshot

Bullrun's latest valuation model marks Recordati Industria Chimica e Farmaceutica S.p.A as 15.4% undervalued; latest market cap is EUR 10.41B; P/E is 22.7; dividend yield is 2.8%.

About Recordati Industria Chimica e Farmaceutica S.p.A

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally. It operates through Specialty and Primary Care; and Rare Diseases segments. The company develops Maapliv for maple syrup urine disease; Isturia for endogenous Cushing's syndrome; Cystadrops treatment of the ocular manifestations of cystinosis;

Frequently asked questions

Is Recordati Industria Chimica e Farmaceutica S.p.A overvalued or undervalued?

Bullrun's valuation model currently marks Recordati Industria Chimica e Farmaceutica S.p.A as 15.4% undervalued.

What is Recordati Industria Chimica e Farmaceutica S.p.A's market cap?

Recordati Industria Chimica e Farmaceutica S.p.A's market capitalization is EUR 10.41B.

What is Recordati Industria Chimica e Farmaceutica S.p.A's P/E ratio?

Recordati Industria Chimica e Farmaceutica S.p.A's price-to-earnings (P/E) ratio is 22.7.

Does Recordati Industria Chimica e Farmaceutica S.p.A pay a dividend?

Recordati Industria Chimica e Farmaceutica S.p.A has a dividend yield of 2.8%.

What does Recordati Industria Chimica e Farmaceutica S.p.A do?

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.